S. Korea Finds New Talc Problem—Excessive Iron In Japanese Batch
This article was originally published in PharmAsia News
South Korean authorities say 24 tons of imported Japanese talc have been found to contain excessive amounts of iron. The Korea Testing and Research Institute for Chemical Industry said it measured iron at levels of 0.29 percent, above the 0.25 percent limit set by the Korea FDA. The shipment from Nippon Talc passed through customs April 1, two days before the agency revised iron-content rules along with an order removing asbestos-tainted talc from the market. Japanese talc usually is preferred by larger drug makers because it is believed to have a higher quality than Chinese talc. (Click here for more
You may also be interested in...
Celltrion's Truxima has become the first rituximab biosimilar, and just the second biosimilar overall, to be prequalified by the World Health Organization.
Fresenius Kabi’s Idacio biosimilar adalimumab rival to Humira will from the start of June be marketed in Germany by Medac, following a deal between the two companies.
Coronavirus Update: Roche Launches Remdesivir Plus Actemra Trial, GSK Plans 1bn Vaccine Adjuvant Doses
Roche is teaming up with Gilead on the combination trial, aiming to improve on results of remdesivir alone, which has failed to show mortality benefits in COVID-19 patients.